SAB Biotherapeutics, Inc. (SABS) has a market capitalization of $36.89M and trades at $3.86. The 52-week range is 1.05-6.6.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 17.5, Earnings Per Share (EPS) of $0.22.
The stock has a beta of 0.61, operates in the Healthcare sector.
